Meuser and Williams Demand Answers from the FDA

Summary

A statement dated June 28, 2023, from Congressman Dan Meuser, Chairman of the Small Business Subcommittee on Economic Growth, Tax, and Capital Access, and Congressman Roger Williams (R-TX), Chairman of the House Committee on Small Business, after sending a letter to Commissioner Califf of the Food and Drug Administration (FDA). Excerpts from the letter concern a proposed rule to create a product standard for cigars that would result in a product ban of all cigars with a ‘characterizing flavor’ other than tobacco. The letter says the Committee reviewed the FDA’s May 2022 Preliminary Regulatory Impact Analysis and identified several unanswered questions about the economic impact of the proposed rule on small entities.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

Meuser and Williams Demand Answers from Commissioner Califf of the Food and Drug Administration on the Impact of New Rule Changes on Small Businesses
Source(print): https://smallbusiness.house.gov/news/documentprint.aspx?DocumentID=405631

Meuser and Williams Demand Answers from Commissioner Califf of the Food and Drug Administration on the Impact of New Rule Changes on Small Businesses 

 smallbusiness.house.gov 

 Cmte Small Business (R) 

 Contact: 

 Meuser and Williams Demand Answers from Commissioner Califf of the Food and Drug Administration on the Impact of New Rule Changes on Small Businesses 

 Meuser and Williams Demand Answers from the FDA 

 Washington ,
 June 28, 2023 
 -

 WASHINGTON, D.C. – Today, Congressman Dan Meuser, Chairman of the Small Business Subcommittee on Economic Growth, Tax, and Capital Access, and Congressman Roger Williams (R-TX), Chairman of the House Committee on Small Business issued the following statements after sending a letter to Commissioner Califf of the Food and Drug Administration (FDA) regarding a new regulation and its potentially adverse impacts on small businesses. 
 This letter builds on the House Committee on Small Business’ work to ensure federal agencies adhere to the Regulatory Flexibility Act and Small Business Regulatory Enforcement Fairness Act to protect small businesses from burdensome regulations and rulemaking. 
 Read the full letter to the Food and Drug Administration here . 
 Read excerpts from the letter below: 
 “The House Committee on Small Business (Committee) writes to inquire about the recent proposed rule to create a product standard for cigars that would result in a product ban of all cigars with a ‘characterizing flavor’ other than tobacco. The Committee has followed the Food and Drug Administration’s (FDA) process as it relates to this rulemaking and seeks to further understand FDA’s consideration of the economic impacts on small entities that would result from implementation of this proposed rule. 
 “Small businesses make up 99.9 percent of all businesses in the United States. This is why the Regulatory Flexibility Act (RFA) requires regulatory agencies to consider the impact of their rules on small businesses, and to evaluate alternatives that would accomplish the objectives of the rule without unduly burdening small entities. We have reviewed the FDA’s May 2022 Preliminary Regulatory Impact Analysis and identified several unanswered questions which we believe should have been considered when assessing the economic impact of the proposed rule.” 
 ###

File and source

File

405631_2023-06-28_meuser-and-williams-demand-answers-from-commission.txt

Size

2,588 bytes

SHA-256

3d14d250dc8384fdd12ad6c818be9fbcb387fec1580660fe0ad18edee5b28e9b

Our copy

405631_2023-06-28_meuser-and-williams-demand-answers-from-commission.txt

Original

No public link identified.